4 Canadian Marijuana Stocks That Could Be Acquired Soon

Share on Linkedin

With signs of industry consolidation, the Canadian marijuana stocks on our list might get gobbled up in good time

SmallCapPower | December 5, 2016: As Canopy Growth Corporation (TSE:CGC) announced recently that it has agreed to acquire Mettrum Health Corp. (CVE:MT), the Number 5 producer by market cap, it leaves a lot for other producers to consider. If the transaction is completed, Canopy will effectively control half of the registered patients under Health Canadians ACMPR. With Aurora Cannabis Inc. (CVE:ACB), and Aphria (CVE:APH) being the Number 2 and Number 3 producers, respectively, they must be thinking about what they are going to do to expand their market share. Although unlikely, it is possible that they merge together to rival the size of the new Canopy Growth Corp., but they could also be eyeing the smaller players in the space. The Canadian marijuana stocks on our list today could be the next ones up for consolidation as the major players look to establish a strong dominance ahead of legalization.

Win Big With Our Small Cap Picks

 

organigram-logoOrganiGram Holdings Inc. (CVE:OGI) – $3.27
Pharmaceuticals

OrganiGram Holdings Inc., formerly Inform Exploration Corp., is a Canada-based company, which operates through its subsidiary Organigram Inc. Organigram Inc. is a licensed medical marijuana producer as regulated by Health Canada under the Marihuana Medical Access Regulations (MMAR) of the Government of Canada.

  • Market Cap: $291.95(mm)
  • Total Revenue (LTM, Default, Millions): $4.94
  • Cash and Short Term Investments (FQ0, Default, Millions): $3.73
  • Total Debt (FQ0, Default, Millions): $7.57organigram-graph

marapharm-logoMarapharm Ventures Inc. (CSE:MDM) – $1.78
Pharmaceuticals

Marapharm Ventures Inc, located in Delta, British Columbia, is a manufacturer of medical marijuana. The Company is engaged in investing, acquiring and starting up ventures in the medical and recreational Marijuana space in North America and other countries. It was founded in April 2007.

  • Market Cap: $113.48(mm)
  • Total Revenue (LTM, Default, Millions): $0.00
  • Cash and Short Term Investments (FQ0, Default, Millions): $0.02
  • Total Debt (FQ0, Default, Millions): $0.68marapharm-graph

supreme-logoSupreme Pharmaceuticals Inc. (CSE:SL) – $1.78
Pharmaceuticals

Supreme Pharmaceuticals Inc. is a Canada-based development-stage company focused on developing businesses in the cannabis market, with a specific focus on the wholesale sector of the medical cannabis market in Canada. The Company operates an approximately 342,000 square foot greenhouse facility located in Kincardine, Ontario. The Company has not generated revenues from its operations.

  • Market Cap: $275.44(mm)
  • Total Revenue (LTM, Default, Millions): $0.00
  • Cash and Short Term Investments (FQ0, Default, Millions): $16.45
  • Total Debt (FQ0, Default, Millions): $4.00supreme-graph

icc-logoICC International Cannabis Corp. (CVE:ICC)- $1.57
Pharmaceuticals

ICC International Cannabis Corp, formerly Shogun Capital Corp, is a Canada-based company, which is a licensed cannabis producer, investigator and vendor. The principal activities of the Company are the production and sale of cannabis from its facilities in Uruguay. The Company is focused on the licensed production, development and sale of recreational cannabis, cannabinoid extracts and by-products for medicinal uses and industrial hemp. The Company is also focused on producing and distributing psychoactive Cannabis for recreational purposes, adult use. In addition, ICC produces and develops hemp sub products. The Company has operations in Uruguay.

  • Market Cap: $8.25(mm)
  • Total Revenue (LTM, Default, Millions): $0.00
  • Cash and Short Term Investments (FQ0, Default, Millions): $0.00
  • Total Debt (FQ0, Default, Millions): $0.09icc-graph